Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.07.523111Source: DataRank Database

Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)OA: greenTopics (32)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Yi Liu ORCID,Jason Wu ORCID,Lenn Fechter,Kanagavel Murugesan ORCID,Holden T. Maecker ORCID

Live enrichment

PubMed:36712071 OpenAlex:https://openalex.org/W4313750696

National Institutes of Health

Grant: 1S10OD021763-01

Computer Cluster

National Institutes of Health

Grant: 5K08HG010061-03

Integrated Clinical and Transcriptomic Profiling to Characterize Disease Phenotype

National Institutes of Health

Grant: 5UL1TR001085-05

Spectrum Stanford Center for clinical and Translational Research and Education

National Institutes of Health

Grant: 1K08HG010061-01A1

Integrated Clinical and Transcriptomic Profiling to Characterize Disease Phenotype

National Institutes of Health

Grant: 3UL1TR001085-04S1

Development of Platelet Transcriptome Signatures in Patients with Myeloproliferative Neoplasms

National Institutes of Health

Grant: 1S10OD018220-01

High Throughput DNA Sequencer Upgrade

NHGRI NIH HHS

Grant: K08 HG010061

NIH HHS

Grant: S10 OD021763

NCATS NIH HHS

Grant: UL1 TR001085

NIH HHS

Grant: S10 OD018220

NCATS NIH HHS

Grant: UL1 TR003142

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/01/12/2023.01.07.523111.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.01.07.523111

repositoryhttp://dx.doi.org/10.1101/2023.01.07.523111

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36712071

Fields of Study

Myeloproliferative Neoplasms: Diagnosis and TreatmentEosinophilic Disorders and SyndromesKruppel-like factors research0301 basic medicine03 medical and health sciences

Keywords

BiologyProteostasisMegakaryocyteDownregulation and upregulationCell biologyEndoplasmic reticulumSmall hairpin RNAUnfolded protein responseCancer researchRNAHaematopoiesisStem cellGeneticsGeneMaleBlood PlateletsMyeloid NeoplasiaMyeloproliferative DisordersAntigens, CD34ArticlePhosphatidylinositol 3-KinasesNeoplasmsHumansCalciumCalmodulin-Binding ProteinsMegakaryocytesAdaptor Proteins, Signal Transducing

Sustainable Development Goals

SDG 0: Good health and well-being